此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Development and Testing of a Clinic-Based Intervention to Increase Dual Protection Against Unintended Pregnancy and Sexually Transmitted Diseases (STDs) Among High Risk Female Teens (2Gether)

2018年11月26日 更新者:Centers for Disease Control and Prevention

This trial will evaluate a multi-component, clinic-based intervention aimed at increasing dual protection strategy selection and adherence among young African American females at an urban family planning clinic. Dual protection is the use of contraceptive strategies to prevent both unintended pregnancy (UIP) and sexually transmitted infections (STIs). This is an unblinded randomized controlled trial; participants will either get the interactive multimedia platform focused on DP strategies with intervention arm counseling or the standard of care arm counseling.

The study will recruit 710 African American females aged 14-19 who are attending the Grady Health System (GHS) Teen Services Clinic (TSC) in Atlanta, Georgia, for reproductive health care.

The trial will recruit and enroll 710 young women presenting to the clinic for clinical care who have the following characteristics:

  • self-identify as African American,
  • 14-19 years of age,
  • have had vaginal sex with a male partner in the past 6 months,
  • HIV-negative by self-report,
  • not pregnant,verified by urine pregnancy test,
  • no desire to be pregnant in next 12 months,
  • plan to stay in the Atlanta area for the next year,
  • are willing to provide contact information, and
  • were not previously enrolled in the pilot study of this intervention.

Those enrolled will be in the study for 12 months. Young women who are eligible and give written consent or assent for study participation will be enrolled. Half will be randomized to the control arm, half to the intervention arm.

  1. Control arm (standard of care) includes individual clinical care and standard of care counseling consistent with protocols at the TSC, with study visits for data collection at enrollment, 6 months, and 12 months, during which any medical care or counseling that they would normally get will also be provided. Control arm participants will also get telephone calls from clinic staff to update their contact information and remind them of upcoming visits at 3 weeks and 5 months after the enrollment visit, and at 3 weeks and 5 months after the 6 month visit.
  2. Intervention arm, consisting of the following intervention components:

    1. Enrollment visit

      • A culturally-appropriate interactive multimedia platform focused on DP strategies and designed to prepare the individual for selection of a DP strategy.
      • Individual intervention arm counseling to select the DP strategy that is best suited for the participant (by a clinic health care provider).
      • Individual intervention arm counseling to build skills for correct and consistent use of the selected DP strategy (by a nurse educator (NE)).
    2. Booster counseling via phone at about 3 weeks and 5 months after the enrollment visit, and at about 3 weeks and 5 months after the 6 month visit (by an NE).
    3. 6 month visit

      • An abbreviated version of the interactive multimedia platform focused on dual protection strategies and strategy adherence.
      • Individual intervention arm counseling to reinforce skills for correct and consistent use of the DP strategy (by an NE).

At the final study visit at 12 months there is no difference between the counseling provided to the two groups; participants in both arms will receive the clinic standard of care.

Participants in both arms of the study will follow the same data collection procedures throughout the study:

  • At all three study visits, participants in both arms will receive urine pregnancy and STI tests and complete an audio computer assisted self-interview (ACASI) questionnaire.
  • At 3 and 9 months after enrollment, participants in both arms will receive a data collection call with administration of a telephone questionnaire.

Throughout the study, all participants will be encouraged to come in for evaluation if they have any concerns. Any data from pregnancy or STI testing at these interim clinic visits will be later collected via chart review. If participants seek reproductive health care at other facilities during the study period, records will be requested with participant permission, and data from pregnancy or STI testing at these outside clinic visits will be collected via review of records received.

We will examine the efficacy of the intervention arm relative to control arm across the following primary behavioral and biologic outcomes over the 12 months of follow-up:

  1. Self-reported dual protection strategy selection
  2. Self-reported dual protection strategy adherence
  3. Incidence of pregnancy or infection with chlamydia, gonorrhea or trichomonas (as confirmed by laboratory testing)

A small pilot study was be conducted prior to the initiation of enrollment in the main study.

研究概览

研究类型

介入性

注册 (实际的)

709

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Georgia
      • Atlanta、Georgia、美国、30303
        • Grady Health System Teen Services Clinic

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

14年 至 19年 (孩子、成人)

接受健康志愿者

是的

有资格学习的性别

女性

描述

Inclusion Criteria:

  • female,
  • self-identify as African American,
  • 14-19 years of age,
  • present to clinic on date of potential enrollment for clinical care,
  • has had vaginal sex with a male partner at least once in the past 6 months,
  • HIV-negative by self-report,
  • not currently pregnant (verified by urine pregnancy test),
  • desire to avoid pregnancy for at least 12 months,
  • plan to be in the Atlanta area for the next 12 months,
  • competent to participate in consenting or assenting process per recruiter evaluation,
  • willing to provide contact information, and
  • not previously enrolled in the pilot study of this intervention.

Exclusion Criteria:

  • pregnant
  • HIV positive

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:预防
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
其他:Control
The control arm receives the clinic standard of care counseling. This includes individual clinical care and counseling consistent with protocols at the Grady Health System Teen Services Clinic, with study visits at enrollment, 6 months, and 12 months, during which any medical care or counseling included in the clinic standard of care will be provided. All control group members will see a provider on the day of enrollment. Control arm participants will get phone calls from clinic staff to update their contact information and remind them of upcoming appointments at 3 weeks and 5 months after both the enrollment visit and the 6 month visit. Participants may visit the clinic at any time and will be encouraged to come into the clinic for any concerns. If they have an interim visit during the study period, they will receive the clinic standard of care.
Standard of care counseling is provided by health care providers and health educators at TSC. It incorporates extensive counseling on methods to prevent both unintended pregnancy and sexually transmitted infections, however the structure of the counseling and techniques used are dependent on the standard practice of each provider or educator. This counseling does not incorporate answers to reflection questions from the multi-media platform because control arm participants will not view this content.
实验性的:Intervention
  1. Enrollment

    • Interactive multimedia platform focused on DP strategies.
    • Intervention arm counseling by a health care provider to select DP strategy.
    • Intervention arm counseling and skill-building by a nurse educator (NE) on correct, consistent use of DP strategy.
  2. Booster counseling by an NE via phone at 3 weeks and 5 months after both the enrollment visit and the 6 month visit.
  3. 6 month visit

    • Abbreviated version of the interactive multimedia platform on DP strategies and adherence.
    • Intervention arm counseling by an NE to reinforce skills for correct, consistent use of DP strategy.
  4. Interim visits: Participants may visit the clinic at any time. If intervention group members visit the clinic for STI treatment or to switch birth control method, providers and/or NEs will follow structured counseling guides. If they have an interim visit for another reason, they will receive the clinic standard of care.
An interactive platform that includes video vignettes of young women who are choosing dual protection strategies (based on a synthesis of focus group data from members of the TSC patient population), as well as true/false questions to build knowledge about dual protection and dispel common myths about contraceptive strategies. There will also be reflection questions that encourage participants to consider values and priorities in their own lives that may influence their dual protection strategy selection.
其他名称:
  • MMDP
Counseling for the intervention group will follow carefully developed guides and incorporate the participants' answers to the reflection questions in the interactive multi-media component. This counseling has a set structure (set forth in separate counseling guides for health care providers and nurse educators), incorporates motivational interviewing techniques, includes multiple opportunities for role play, and is designed to be patient-centered.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Participant selection of an effective dual protection (DP) strategy
大体时间:6 months

Whether or not a participant self-reports having selected an effective DP strategy. An effective DP strategy is defined as one of the following:

  • Abstinence from vaginal sex;
  • Effective non-barrier contraceptive method [including intrauterine device (IUD), Implant, Depo, or contraceptive pill, patch or ring] with consistent condom use;
  • Consistent condom use only
6 months
Participant report of adherence to DP strategy
大体时间:3 months

By self-report from audio computer-assisted self-interviewing (ACASI) and telephone questionnaires; adherence is measured by three different outcomes:

  • Whether or not DP strategy was used at last sex
  • Whether or not DP strategy was used consistently during last 3 month time period
  • Estimated proportion of time adherent to DP strategy over last 3 months
3 months
Time to first biologic event (pregnancy or diagnosis with STI) in participants
大体时间:Within 12 month period following enrollment
Measured by date of positive lab test ("biologic event" refers to a positive pregnancy test or diagnosis with chlamydia, gonorrhea or trichomonas infection).
Within 12 month period following enrollment
Incidence of pregnancy and sexually transmitted infections (STIs)
大体时间:Within 12 month period following enrollment
Includes the proportion of participants with a lab-confirmed diagnosis of pregnancy or lab-confirmed diagnosis with infection with chlamydia, gonorrhea or trichomonas within the 12 month follow-up period (testing either performed at study site clinic and documented at study visits and via chart review, or diagnosed by outside labs with documentation obtained via release of information procedures)
Within 12 month period following enrollment
Participant selection of an effective dual protection (DP) strategy
大体时间:12 months

Whether or not a participant self-reports having selected an effective DP strategy. An effective DP strategy is defined as one of the following:

  • Abstinence from vaginal sex;
  • Effective non-barrier contraceptive method [including intrauterine device (IUD), Implant, Depo, or contraceptive pill, patch or ring] with consistent condom use;
  • Consistent condom use only
12 months
Participant report of adherence to DP strategy
大体时间:6 months

By self-report from audio computer-assisted self-interviewing (ACASI) and telephone questionnaires; adherence is measured by three different outcomes:

  • Whether or not DP strategy was used at last sex
  • Whether or not DP strategy was used consistently during last 3 month time period
  • Estimated proportion of time adherent to DP strategy over last 3 months
6 months
Participant report of adherence to DP strategy
大体时间:9 months

By self-report from audio computer-assisted self-interviewing (ACASI) and telephone questionnaires; adherence is measured by three different outcomes:

  • Whether or not DP strategy was used at last sex
  • Whether or not DP strategy was used consistently during last 3 month time period
  • Estimated proportion of time adherent to DP strategy over last 3 months
9 months
Participant report of adherence to DP strategy
大体时间:12 months

By self-report from audio computer-assisted self-interviewing (ACASI) and telephone questionnaires; adherence is measured by three different outcomes:

  • Whether or not DP strategy was used at last sex
  • Whether or not DP strategy was used consistently during last 3 month time period
  • Estimated proportion of time adherent to DP strategy over last 3 months
12 months
Participant selection of an effective dual protection (DP) strategy
大体时间:At enrollment visit

Whether or not a participant self-reports having selected an effective DP strategy. An effective DP strategy is defined as one of the following:

  • Abstinence from vaginal sex;
  • Effective non-barrier contraceptive method [including intrauterine device (IUD), Implant, Depo, or contraceptive pill, patch or ring] with consistent condom use;
  • Consistent condom use only
At enrollment visit

次要结果测量

结果测量
措施说明
大体时间
Participant level of reproductive health knowledge (percentage correct of knowledge questions)
大体时间:6 months
Knowledge about contraceptives and STIs, as measured by correct answers to knowledge questions on ACASI questionnaires.
6 months
Participant intention to use DP strategy
大体时间:6 months
Whether or not participant self-reports intention to use an effective DP strategy in the future, as measured by responses on ACASI questionnaires.
6 months
Participant reproductive health self-efficacy
大体时间:6 months
Whether or not participant reported high self-efficacy for condom use, contraceptive use, and communication with partner on reproductive health topics, as measured by responses on ACASI questionnaires.
6 months
Participant report of STI testing
大体时间:6 months
Frequency of self-reported STI testing by participant and partner(s) and result-sharing with partner(s), as measured by responses to ACASI questionnaires.
6 months
Participant report of partner communication
大体时间:6 months
Self-reported frequency of communication with partner on reproductive health topics, as measured by responses on ACASI questionnaires.
6 months
Participant level of reproductive health knowledge (percentage correct of knowledge questions)
大体时间:12 months
Knowledge about contraceptives and STIs, as measured by correct answers to knowledge questions on ACASI questionnaires.
12 months
Participant intention to use DP strategy
大体时间:12 months
Whether or not participant self-reports intention to use an effective DP strategy in the future, as measured by responses on ACASI questionnaires.
12 months
Participant report of STI testing
大体时间:12 months
Frequency of self-reported STI testing by participant and partner(s) and result-sharing with partner(s), as measured by responses to ACASI questionnaires.
12 months
Participant reproductive health self-efficacy
大体时间:12 months
Whether or not participant reported high self-efficacy for condom use, contraceptive use, and communication with partner on reproductive health topics, as measured by responses on ACASI questionnaires.
12 months
Participant report of partner communication
大体时间:12 months
Self-reported frequency of communication with partner on reproductive health topics, as measured by responses on ACASI questionnaires.
12 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Melissa Kottke, MD MPH MBA、Emory University; Grady Health System
  • 首席研究员:Jessica Sales, PhD、Emory University
  • 首席研究员:Athena Kourtis, MD PhD MPH、Centers for Disease Control and Prevention
  • 研究主任:Peggy Goedken, MPH、Emory University

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2015年3月1日

初级完成 (实际的)

2018年8月1日

研究完成 (实际的)

2018年8月1日

研究注册日期

首次提交

2014年7月24日

首先提交符合 QC 标准的

2014年11月12日

首次发布 (估计)

2014年11月14日

研究记录更新

最后更新发布 (实际的)

2018年11月27日

上次提交的符合 QC 标准的更新

2018年11月26日

最后验证

2018年11月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • CDC-NCCDPHP-6588
  • DP12-001 (其他赠款/资助编号:CDC)

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

未定

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅